Olivo Alicia C's Form 4 filing
Neogenomics Inc (NEO) · filed Oct 20, 2025
- Accession no.
- 0001628280-25-045529
- Filed
- Oct 20, 2025
- Trade date
- Oct 16, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $49.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Olivo Alicia CCIK 0001951869 | Officer (EVP, GC & Business Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2025 | Common Stock | SSaleDisposed | −4,918 | $10.00 | −$49,180 | 43,022 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.